The combined oral contraceptive Zoely® (Merck, Sharp, and Dohme Limited) has been licensed in Europe since 2011 and will be available in the UK from May 2013. Zoely will be the second UK combined oral contraceptive (COC) to contain estradiol and to be formulated as an extended regimen since the introduction of Qlaira® (Bayer plc.)
These Standards are recommended for organisations providing contraceptive/sexual and reproductive health (SRH) services, including pregnancy planning, pregnancy choices, abortion, prevention and treatment of sexually transmitted infections (STIs), as well as sexual wellbeing and health promotion.
This document provides standards for resuscitation in sexual and reproductive health service settings. This document should be used in conjunction with national guidelines from other relevant professional bodies and locally agreed policies and procedures. It is important that each service identifies the level of equipment and training needed to deal with common emergencies on the basis of a local risk assessment.
This statement provides guidance on contraceptive options for women with prolactinoma
FSRH Clinical Guideline: Management of Vaginal Discharge in Non-Genitourinary Medicine Settings (February 2012), Lapsed Guideline
Please note, this guidance document has lapsed. Up to date guidance on this topic can be found at: http://www.rcgp.org.uk/clinical-and-research/clinical-resources/sexually-transmitted-infections-in-primary-care.aspx
NICE supports the use of hysteroscopic sterilisation provided that normal arrangements are in place for clinical governance and audit.
Please note this item was archived in June 2012
Statement from the FSRH Clinical Standards Committee, the Clinical Effectiveness Committee and the Associate Members’ Working Group on the prescription, administration or supply of Contraceptive Medicines for use outside the terms of their licences Dec 09
The above committees have agreed that Clinical Effectiveness Unit Guidance on use of contraceptives is guidance on “common practice” and “current practice” in the use of these medicines and devices. Therefore it is recommended that it may not be necessary for clinicians to document every occasion when a contraceptive preparation is prescribed outside the product licence if such use falls within current guidance issued by the Faculty’s Clinical Effectiveness Unit.
Emergency Contraception - This document may have been updated since initial publication.
It has always been a professional responsibility to provide the highest standard of care within the community. However, recently, doctors within the United Kingdom are expected to be able to demonstrate their fitness to practice within clinical governance and revalidation. In line with other professional groups and particularly in line with the Colleges and Faculties with whom we work - the RCOG, the RCGP and the Faculty of Public Health Medicine - it is important for us to demonstrate the elements of maintaining good medical practice within our specialist areas.